Comprehensive Analysis and Experimental Validation of HEPACAM2as a Potential Prognosis Biomarker and Immunotherapy Target inColorectal Cancer
These findings suggest that HEPACAM2 may serve as a potential prognostic biomarker and immunotherapeutic target for CRC patients.
Authors
- Miaomiao Gou (ORCID: https://orcid.org/0000-0001-9622-1198)
- Lijuan Zhang (ORCID: https://orcid.org/0000-0003-1074-5631)
- Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)
- Wang Shouguang
Institutions
- Qingdao University (CN)
- People's Liberation Army No. 150 Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Current Gene Therapy
- Published
- 2024-11-04
- DOI
- https://doi.org/10.2174/0115665232325395241018103006
- Citations
- 12
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.39